Long‐acting injectable cabotegravir for PrEP: a game‐changer in HIV prevention?
G Liegeon, J Ghosn - HIV medicine, 2023 - Wiley Online Library
Background Long‐acting injectable cabotegravir (CAB‐LA) represents a new additional
option for HIV prevention in people at substantial risk of HIV infection that may fill the gaps in …
option for HIV prevention in people at substantial risk of HIV infection that may fill the gaps in …
Interrogating the promise of long-acting HIV pre-exposure prophylaxis
Oral HIV pre-exposure prophylaxis (PrEP) is a well-established product that provides a safe
and highly effective way for individuals to protect themselves against HIV infection. However …
and highly effective way for individuals to protect themselves against HIV infection. However …
[HTML][HTML] HIV epidemic, prevention technologies, and the new generations: trends and opportunities for epidemic response
Abstract The United Nations has underscored the possibility of ending the HIV epidemic as a
public health problem. However, an increase in the incidence among adolescents and youth …
public health problem. However, an increase in the incidence among adolescents and youth …
The perceived added value of bimonthly injectable pre-exposure prophylaxis according to West African men who have sex with men: a focus group study
T Reyniers, M Fiorentino, SAY Babo… - AIDS Patient Care …, 2023 - liebertpub.com
Bimonthly long-acting injectable pre-exposure prophylaxis (LAI-PrEP) can become an
important additional tool for HIV prevention among West African men who have sex with …
important additional tool for HIV prevention among West African men who have sex with …
Acceptability and tolerability of long-acting injectable cabotegravir or rilpivirine in the first cohort of virologically suppressed adolescents living with HIV (IMPAACT …
ED Lowenthal, J Chapman, R Ohrenschall… - The Lancet …, 2024 - thelancet.com
Background Long-acting injectable cabotegravir and rilpivirine have demonstrated safety,
acceptability, and efficacy in adults living with HIV-1. The IMPAACT 2017 study (MOCHA …
acceptability, and efficacy in adults living with HIV-1. The IMPAACT 2017 study (MOCHA …
Considerations for long-acting antiretroviral therapy in older persons with HIV
People with HIV (PWH) can now enjoy longer, healthier lives due to safe and highly effective
antiretroviral therapy (ART), and improved care and prevention strategies. New drug …
antiretroviral therapy (ART), and improved care and prevention strategies. New drug …
Multilevel factors impacting PrEP Engagement among young gay men and young transgender women in thailand: a qualitative analysis
Half of new HIV infections in Thailand are among young people, the majority of whom are
young gay and other men who have sex with men (YMSM) and young transgender women …
young gay and other men who have sex with men (YMSM) and young transgender women …
Predictors of human immunodeficiency virus pre-exposure prophylaxis (PrEP) uptake in a sexual health clinic with rapid PrEP initiation
GA Wagner, KS Wu, C Anderson… - Open forum infectious …, 2023 - academic.oup.com
Background Improved pre-exposure prophylaxis (PrEP) uptake is essential for human
immunodeficiency virus (HIV) prevention initiatives. Offering PrEP at the time of HIV and …
immunodeficiency virus (HIV) prevention initiatives. Offering PrEP at the time of HIV and …
“What Is the Benefit?”: perceptions and preferences for long-acting injectable antiretroviral therapy among people living with HIV
H Gonzalez Rodriguez, AI Volcan… - AIDS Education and …, 2023 - Guilford Press
Long-acting injectable antiretroviral therapy (LA-ART) expands treatment options for people
living with HIV (PLWH). This qualitative study characterizes LA-ART awareness …
living with HIV (PLWH). This qualitative study characterizes LA-ART awareness …
[HTML][HTML] Ensuring People Living with HIV Inform the Future of HIV Treatment in Low-and Middle-Income Countries: A Scoping Review and Recommendations for a …
DF Resar, R Sapire, B Caldwell, S Jenkins… - AIDS and Behavior, 2024 - Springer
The HIV treatment landscape in low-and middle-income countries (LMICs) is rapidly
evolving, exemplified by the expansion of differentiated service delivery (DSD) during the …
evolving, exemplified by the expansion of differentiated service delivery (DSD) during the …